NCT00914303View on ClinicalTrials.gov

Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Healthy
Interventions
DRUG

AZD3241

Oral Tablet, Repeated Administration

DRUG

Placebo Tablet

Oral Tablet. Repeated Administration

Trial Locations (1)

Unknown

Research Site, Uppsala

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY